The company has also signed the first European distribution agreements for MDS with Mokascience in France, Bucher Biotec in Switzerland and KRD Molecular Technologies in the Czech Republic, Slovakia and Hungary.
The one-step workflow of the Maverick multiplex system can deliver accurate results in as little as 15 minutes from small volume samples of many types, according to the company.
Genalyte chief scientific officer Martin Gleeson said, "The Maverick System and our growing family of multiplex assays have generated a great deal of interest in Europe, so this CE mark designation and the appointment of our first European distributors are especially timely."
Maverick assays are currently available for research use only.